Preclinical study of rAAV2-sTRAIL: pharmaceutical efficacy, biodistribution and safety in animals
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Gene Therapy"
DOI: 10.1038/cgt.2017.12
Abstract: The recombinant sTRAIL has been in clinical trial for various human malignancies. However, the half-life time of sTRAIL is very short, which might be an important factor influencing its clinical efficacy for cancer therapy. We… read more here.
Keywords: safety; efficacy; raav2 strail95; strail95 281 ... See more keywords